← Back to Search

Laser Sheath

Laser Scope Size Comparison for Prostate Enlargement

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males aged 18-89 undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights

Study Summary

This trial is comparing two different sizes of laser scopes to see which is better at removing obstructing prostate tissue during HoLEP.

Who is the study for?
This trial is for men aged 18-89 who are undergoing HoLEP to treat bothersome symptoms from an enlarged prostate. Participants must be able to make their own decisions about healthcare.Check my eligibility
What is being tested?
The study compares two laser scopes used in HoLEP surgery: the Richard Wolf 24F and the Karl Storz 28F, to see which might be better for removing obstructing prostate tissue through the urethra.See study design
What are the potential side effects?
Potential side effects may include discomfort or complications related to scope size during the procedure, such as bleeding, infection, or urinary issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man aged 18-89 with urinary problems planning to undergo HoLEP.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surgery Time difference between the 24F laser scope and the 28F laser scope
Secondary outcome measures
Surgeon evaluation of Laser scope bladder injury
Surgeon evaluation of Laser scope visualization
Surgeon evaluation of Laser scopes flow rate

Trial Design

2Treatment groups
Active Control
Group I: Richard Wolf 24F Laser scopeActive Control1 Intervention
Group II: Karl Storz 28F Laser scopeActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,079 Total Patients Enrolled

Media Library

Karl Storz 28F Laser Scope (Laser Sheath) Clinical Trial Eligibility Overview. Trial Name: NCT05308017 — N/A
Benign Prostatic Hyperplasia Research Study Groups: Richard Wolf 24F Laser scope, Karl Storz 28F Laser scope
Benign Prostatic Hyperplasia Clinical Trial 2023: Karl Storz 28F Laser Scope Highlights & Side Effects. Trial Name: NCT05308017 — N/A
Karl Storz 28F Laser Scope (Laser Sheath) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05308017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to join this clinical trial?

"Confirmed, this clinical trial is still searching for participants. According to the information posted on clinicaltrials.gov, it was created on May 1st 2022 and has been recently updated on June 5th of the same year."

Answered by AI

Could I become part of this experimental investigation?

"This clinical trial is enrolling 50 males aged 18 to 89 with bothersome lower urinary tract symptoms associated with adenoma prostatic who will be receiving HoLEP treatment. Eligibility criteria must be met by all participants."

Answered by AI

What is the cap on admission to this clinical trial?

"Absolutely. According to the data found on clinicaltrials.gov, this trial is currently enrolling participants with a commencement date of May 1st 2022 and an updated status as recently as June 5th 2022. 50 patients are required from one medical centre for the study's completion."

Answered by AI

Does the trial include individuals above 20 years of age?

"The requirements for participating in this medical trial indicate that any individual aged 18-89 can apply. Additionally, 15 trials are available to minors and 134 are designed specifically with seniors in mind."

Answered by AI
~52 spots leftby Apr 2025